News

Zacks Investment Research on MSN15h
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
Novo Nordisk stock plunges 22% after slashing 2025 sales and profit outlooks, citing weak GLP-1 drugs' uptake and rising ...
The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Zacks.com on MSN13d
Why Novo Nordisk (NVO) is a Great Dividend Stock Right Now
Novo Nordisk (NVO) is headquartered in Bagsvaerd ... Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).
Top Research Reports for SAP, Novo Nordisk & Thermo Fisher
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
Nasdaq22d
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo ... - Nasdaq
Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Novo Nordisk A/S and Thermo Fisher Scientific Inc., as well a micro-cap stock FONAR Corp.
Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know
Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...
The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%.
The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...